← Back to Search

Best practice alert (BPA) intervention group for Prophylaxis of Preeclampsia

N/A

Recruiting

Led By A. Dhanya Mackeen, MD, MPH

Research Sponsored by Geisinger Clinic

Eligibility Criteria Checklist

Specific guidelines that determine who can or cannot participate in a clinical trial

Must have

Timeline

Screening 3 weeks

Treatment Varies

Follow Up assessed at delivery

Awards & highlights

Study Summary

This trial aims to see if using a computer tool called an electronic health record (EHR) clinical decision support tool can help healthcare providers make better recommendations for low dose aspirin use in pregnant patients at

Who is the study for?

This trial is for pregnant individuals under the care of Geisinger who are less than 28 weeks along and at high risk for preeclampsia, as determined by specific medical guidelines. It's not specified who can't join.Check my eligibility

What is being tested?

The study tests if a new alert in doctors' electronic health records increases recommendations for low dose aspirin to prevent preeclampsia in high-risk pregnancies compared to usual care.See study design

What are the potential side effects?

Since this trial focuses on the use of an electronic alert system rather than a drug or medical procedure, there are no direct side effects associated with its implementation.

Timeline

Screening ~ 3 weeks3 visits

Treatment ~ Varies

Follow Up ~ assessed between initial prenatal visit and delivery

Screening ~ 3 weeks

Treatment ~ Varies

Follow Up ~assessed between initial prenatal visit and delivery

This trial's timeline: 3 weeks for screening, Varies for treatment, and assessed between initial prenatal visit and delivery for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.

Primary outcome measures

A sensitivity analysis of the healthcare provider recommendation for low dose aspirin use in patients, specifically those who deliver after 28 weeks

Secondary outcome measures

The healthcare provider recommendation for low dose aspirin use in all randomized patients

Other outcome measures

Number of times the best practice alert fired for a patient

Patient taking low dose aspirin

Preterm delivery

+4 more

Trial Design

2Treatment groups

Active Control

Group I: Best practice alert (BPA) intervention groupActive Control1 Intervention

An electronic health record best practice alert (BPA) will alert healthcare providers to recommend low dose aspirin for pregnant patients at high-risk for preeclampsia. This alert also allows the healthcare provider to order an over-the-counter-prescription for low dose aspirin and automatically documents LDA in the patient's medication list.

Group II: Standard care groupActive Control1 Intervention

Healthcare provider's recommendation for aspirin in patients at high-risk for preeclampsia will be based on current practice (no alerts) and the healthcare provider's knowledge.

Do I qualify?Apply below to find out

Find a Location

Who is running the clinical trial?

Geisinger ClinicLead Sponsor

149 Previous Clinical Trials

1,885,495 Total Patients Enrolled

A. Dhanya Mackeen, MD, MPHPrincipal InvestigatorGeisinger Clinic

1 Previous Clinical Trials

746 Total Patients Enrolled

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

What is the current number of individuals eligible for enrollment in this clinical research study?

"Indeed, as stated on clinicaltrials.gov, this investigation is currently seeking eligible participants. The trial was first published on June 19th, 2023 and last updated on January 9th, 2024. A total of 640 individuals are being sought at a single site for enrollment in the study."

Answered by AI

Are there currently any available slots for new participants in this medical trial?

"Indeed, information retrieved from clinicaltrials.gov indicates that this trial is actively seeking participants. The initial posting date was on June 19th, 2023, and the most recent update occurred on January 9th, 2024. A total of 640 patients are being sought at a single designated site."

Answered by AI

Recent research and studies

Obstetrics & GynecologyJournal

ACOG Committee Opinion No. 743: Low-dose Aspirin Use During Pregnancy

“ACOG Committee Opinion No. 743: Low-dose Aspirin Use During Pregnancy”. 2018. “ACOG Committee Opinion No. 743: Low-dose Aspirin Use During Pregnancy”. Obstetrics & Gynecology. Ovid Technologies (Wolters Kluwer Health). doi:10.1097/aog.0000000000002708.

clinicaltrials.govStudy

Low Dose Aspirin Alerts in High-Risk Pregnancies

Awathif Dhanya Mackeen 2023. "Low Dose Aspirin Alerts in High-Risk Pregnancies". ClinicalTrials.gov. https://clinicaltrials.gov/ct2/show/NCT05802940.